Oral Citrate Supplementation Mitigates Age‐Associated Pathologic Intervertebral Disc Calcification in LG /J Mice
Aging Cell · 2025
DOI: 10.1111/acel.14504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Olivia K Ottone und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Calcinosis, Intervertebral Disc, Dietary Supplements, Citric Acid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Despite the high prevalence of age‐dependent intervertebral disc calcification, there is a glaring lack of treatment options for this debilitating pathology. We investigated the efficacy of long‐term oral K 3 Citrate supplementation in ameliorating disc calcification in LG/J mice, a model of spontaneous age‐associated disc calcification. K 3 Citrate reduced the incidence of disc calcification without affecting the vertebral bone structure, knee calcification, plasma chemistry, or locomotion in LG/J mice. Notably, a positive effect on grip strength was evident in treated mice. FTIR spectroscopy of the persisting calcified nodules indicated K 3 Citrate did not alter the mineral composition. Mechanistically, activation of an endochondral differentiation in the cartilaginous endplates and nucleus pulposus (NP) compartment contributed to LG/J disc calcification. Importantly, K 3 Citrate reduced calcification incidence by Ca 2+ chelation throughout the disc while exhibiting a differential effect on NP and endplate cell differentiation. In the NP compartment, K 3 Citrate reduced the NP cell acquisition of a hypertrophic chondrocytic fate, but the pathologic endochondral program was unimpacted in the endplates. Overall, this study for the first time shows the therapeutic potential of oral K 3 Citrate as a systemic intervention strategy to ameliorate disc calcification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Graduate Program in Cell Biology and Regenerative Medicine, Jefferson College of Life Sciences, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- LabCorp, Morrisville, North Carolina, USA.
- PXE International Center of Excellence for Research and Clinical Care, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Olivia K Ottone, Jorge J Mundo, Makarand V Risbud
Förderung
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Ottone, O. K., Mundo, J. J., Kwakye, B. N., Slaweski, A., Collins, J. A., Wu, Q., Connelly, M. A., Niaziorimi, F., van de Wetering, K., & Risbud, M. V. (2025). Oral Citrate Supplementation Mitigates Age‐Associated Pathologic Intervertebral Disc Calcification in LG /J Mice. Aging Cell. https://doi.org/10.1111/acel.14504
Vancouver
Ottone OK, Mundo JJ, Kwakye BN, Slaweski A, Collins JA, Wu Q, et al. Oral Citrate Supplementation Mitigates Age‐Associated Pathologic Intervertebral Disc Calcification in LG /J Mice. Aging Cell. 2025. doi:10.1111/acel.14504
BibTeX
@article{Ottone2025,
author = {Ottone, Olivia K and Mundo, Jorge J and Kwakye, Boahen N and Slaweski, Amber and Collins, John A and Wu, Qinglin and Connelly, Margery A and Niaziorimi, Fatemeh and van de Wetering, Koen and Risbud, Makarand V},
title = {Oral Citrate Supplementation Mitigates Age‐Associated Pathologic Intervertebral Disc Calcification in LG /J Mice},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.14504}
}
EUVIMED